Key facts
- This page summarizes Christopher Burke Gaskill's Form 4 filing for CARLISLE COMPANIES INC (CSL).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 29 Jan 2026, 16:03.
Christopher Burke Gaskill - 28 Jan 2026 Form 4 Insider Report for CARLISLE COMPANIES INC (CSL)
- Reporting relationship
- VP & General Counsel
- Issuer ticker
- CSL
- Reported as of
- 28 Jan 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 29 Jan 2026, 16:03:43 UTC
- Prior SEC filing
- 19 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christopher B. Gaskill by Ronald P. Fuss, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Christopher Burke Gaskill filed Form 4 for CARLISLE COMPANIES INC (CSL) on 29 Jan 2026.
Change
- Previous filing in this sequence was filed on 19 May 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001854269
Primary reporting owner
Gaskill Christopher Burke
- Relationship
- VP & General Counsel
- Address
- 16430 N SCOTTSDALE RD, STE 400, SCOTTSDALE
- Signature
- /s/ Christopher B. Gaskill by Ronald P. Fuss, attorney-in-fact
- Signature date
- 29 Jan 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CSL
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +865
- Change %
- Price
- $0.000000
- Shares after
- 865
- Date
- 28 Jan 2026
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CSL
transaction
Derivative
Employee Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +3,025
- Change %
- Price
- $0.000000
- Shares after
- 3,025
- Date
- 28 Jan 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,025
- Exercise price
- $341.01
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents a grant of 865 restricted shares from the issuer as an executive officer of the issuer.
Footnote F2
The option vests in three equal annual installments beginning on January 28, 2027.